Cardiothoracic & vascular anaesthesia

Ultrasound-Guided Stellate Ganglion Block Regulates Inflammatory Cytokines and Improves Short-Term Outcome after Cardiac Surgery with Cardiopulmonary Bypass: A Randomized Clinical Trial

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Authors' conclusion

SGB effectively improves short-term outcomes in patients with cardiac surgery and CPB, possibly through modulating the neuro-endocrine-immune network to normalize sympathetic nervous system activity and stabilize perioperative tumor necrosis factor-α concentration.

Study context

Population
Patients aged 18 to 70 scheduled for cardiac surgery with cardiopulmonary bypass (CPB)analysed
Participants
25 vs 25
Comparison
Stellate ganglion block (SGB) vs Control
  • SGBn = 25
  • Controln = 25reference
Primary endpoint
Inflammatory cytokine concentration before (T0) and 6 h (T1), 24 h (T2), and 5 days (T3) after the block
Methodological detailsprospective, double-blinded, single-centre
  • Prospective
  • Double-blinded
  • Single-centre

Primary result

As reported in the abstract

TNF-α concentration · 6 and 24 hours after the block
SGB significantly inhibited elevated TNF-α concentration vs control
p < 0.05

Secondary outcomes

SIRS 24 hours after surgery

Significantly reduced with SGB

Immune function (neutrophil and lymphocyte percentage)

SGB decreased neutrophil percentage at 6 h and increased lymphocyte percentage at 5 days after the block

Safety

Complications: ventricular fibrillation after reperfusion, postoperative delirium, Clavien-Dindo grade III-IV

Decreased with SGB

Original publication

Ultrasound-Guided Stellate Ganglion Block Regulates Inflammatory Cytokines and Improves Short-Term Outcome after Cardiac Surgery with Cardiopulmonary Bypass: A Randomized Clinical Trial. J Cardiothorac Vasc Anesth. Published 15 June 2025. doi:10.1053/j.jvca.2025.06.024

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.